Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of Angiogenesis-Related Genes as Prognostic Biomarkers of Bevacizumab Treated Ovarian Cancer Patients: Results from the Phase IV MITO16A/ManGO OV-2 Translational Study.
Califano D, Gallo D, Rampioni Vinciguerra GL, De Cecio R, Arenare L, Signoriello S, Russo D, Ferrandina G, Citron F, Losito NS, Gargiulo P, Simeon V, Scambia G, Cecere SC, Montella M, Colombo N, Tognon G, Bignotti E, Zannoni GF, Canzonieri V, Ciucci A, Spina A, Scognamiglio G, Del Sesto M, Schettino C, Piccirillo MC, Perrone F, Chiodini P, Pignata S, Baldassarre G. Califano D, et al. Among authors: citron f. Cancers (Basel). 2021 Oct 14;13(20):5152. doi: 10.3390/cancers13205152. Cancers (Basel). 2021. PMID: 34680301 Free PMC article.
p27kip1 at the crossroad between actin and microtubule dynamics.
Rampioni Vinciguerra GL, Citron F, Segatto I, Belletti B, Vecchione A, Baldassarre G. Rampioni Vinciguerra GL, et al. Among authors: citron f. Cell Div. 2019 Apr 1;14:2. doi: 10.1186/s13008-019-0045-9. eCollection 2019. Cell Div. 2019. PMID: 30976290 Free PMC article.
Downregulation of miR-223 Expression Is an Early Event during Mammary Transformation and Confers Resistance to CDK4/6 Inhibitors in Luminal Breast Cancer.
Citron F, Segatto I, Vinciguerra GLR, Musco L, Russo F, Mungo G, D'Andrea S, Mattevi MC, Perin T, Schiappacassi M, Massarut S, Marchini C, Amici A, Vecchione A, Baldassarre G, Belletti B. Citron F, et al. Cancer Res. 2020 Mar 1;80(5):1064-1077. doi: 10.1158/0008-5472.CAN-19-1793. Epub 2019 Dec 20. Cancer Res. 2020. PMID: 31862778
CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.
Viotto D, Russo F, Anania I, Segatto I, Rampioni Vinciguerra GL, Dall'Acqua A, Bomben R, Perin T, Cusan M, Schiappacassi M, Gerratana L, D'Andrea S, Citron F, Vit F, Musco L, Mattevi MC, Mungo G, Nicoloso MS, Sonego M, Massarut S, Sorio R, Barzan L, Franchin G, Giorda G, Lucia E, Sulfaro S, Giacomarra V, Polesel J, Toffolutti F, Canzonieri V, Puglisi F, Gattei V, Vecchione A, Belletti B, Baldassarre G. Viotto D, et al. Among authors: citron f. J Pathol. 2021 Feb;253(2):234-245. doi: 10.1002/path.5584. Epub 2020 Dec 4. J Pathol. 2021. PMID: 33140857 Free PMC article.
miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC.
Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra GL, Franchin G, Fanetti G, Miccichè F, Giacomarra V, Lupato V, Favero A, Concina I, Srinivasan S, Avanzo M, Castiglioni I, Barzan L, Sulfaro S, Petrone G, Viale A, Draetta GF, Vecchione A, Belletti B, Baldassarre G. Citron F, et al. EMBO Mol Med. 2021 Jul 7;13(7):e12872. doi: 10.15252/emmm.202012872. Epub 2021 Jun 1. EMBO Mol Med. 2021. PMID: 34062049 Free PMC article.
Loss of CDKN1B induces an age-related clonal hematopoietic disorder via Notch2 activity dysregulation.
Segatto I, Rampioni Vinciguerra GL, Pellarin I, Dall'Acqua A, Berton S, Citron F, D'Andrea S, Mungo G, Viotto D, Musco L, Di Napoli A, Aloe Spiriti MA, Canzonieri V, Gattei V, Vecchione A, Belletti B, Baldassarre G. Segatto I, et al. Among authors: citron f. Cancer Commun (Lond). 2023 Jul;43(7):844-849. doi: 10.1002/cac2.12444. Epub 2023 Jun 19. Cancer Commun (Lond). 2023. PMID: 37337406 Free PMC article. No abstract available.
An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D'Andrea S, Sulfaro S, Croce CM, Klement W, Otasek D, Pastrello C, Tokar T, Jurisica I, French D, Bomben R, Vaccher E, Serraino D, Belletti B, Vecchione A, Barzan L, Baldassarre G. Citron F, et al. Clin Cancer Res. 2017 Jul 15;23(14):3769-3780. doi: 10.1158/1078-0432.CCR-16-2814. Epub 2017 Feb 7. Clin Cancer Res. 2017. PMID: 28174235 Free PMC article.
34 results